STK39 (serine/threonine kinase 39)

2006-10-01  

Identity

HGNC
LOCATION
2q24.3
LOCUSID
ALIAS
DCHT,PASK,SPAK
FUSION GENES

Other Information

Locus ID:

NCBI: 27347
MIM: 607648
HGNC: 17717
Ensembl: ENSG00000198648

Variants:

dbSNP: 27347
ClinVar: 27347
TCGA: ENSG00000198648
COSMIC: STK39

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000198648ENST00000355999Q9UEW8

Expression (GTEx)

0
10
20
30
40
50
60
70

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA134875400WNK4GenePathwayassociated23788015
PA134973207OXSR1GenePathwayassociated23788015
PA321SLC12A3GenePathwayassociated23788015
PA33782WNK1GenePathwayassociated23788015
PA33784WNK3GenePathwayassociated23788015
PA450268losartanChemicalClinicalAnnotationassociatedPD21993215

References

Pubmed IDYearTitleCitations
365382422023CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathway.2
365382422023CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathway.2
347268262022Structures of the Human SPAK and OSR1 Conserved C-Terminal (CCT) Domains.1
347268262022Structures of the Human SPAK and OSR1 Conserved C-Terminal (CCT) Domains.1
342814922021Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.9
343359562021STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation.6
343746382021Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis.14
345196352021Knockdown of STK39 suppressed cell proliferation, migration, and invasion in hepatocellular carcinoma by repressing the phosphorylation of mitogen-activated protein kinase p38.2
346788962021Variant rs6749447 (T > G) in the serine threonine kinase gene is associated with cardiovascular complications, the Tampere adult population cardiovascular risk study.1
342814922021Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.9
343359562021STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation.6
343746382021Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis.14
345196352021Knockdown of STK39 suppressed cell proliferation, migration, and invasion in hepatocellular carcinoma by repressing the phosphorylation of mitogen-activated protein kinase p38.2
346788962021Variant rs6749447 (T > G) in the serine threonine kinase gene is associated with cardiovascular complications, the Tampere adult population cardiovascular risk study.1
316140642020The Cul4-DDB1-WDR3/WDR6 Complex Binds SPAK and OSR1 Kinases in a Phosphorylation-Dependent Manner.9

Citation

Dessen P

STK39 (serine/threonine kinase 39)

Atlas Genet Cytogenet Oncol Haematol. 2006-10-01

Online version: http://atlasgeneticsoncology.org/gene/43518/gene-fusions/tumors-explorer/js/lib/jquery-3.5.1.min.js